CodeSystem |
https://demis.rki.de/fhir/CodeSystem/translationNullFlavor | Übersetzung NullFlavor |
http://hl7.org/fhir/us/vrdr/ConceptMap/CertifierTypesCM | CertifierTypes Concept Map |
http://hl7.org/fhir/us/vrdr/ConceptMap/ContributoryTobaccoUseCM | ContributoryTobaccoUse Concept Map |
http://hl7.org/fhir/us/vrdr/ConceptMap/DeathPregnancyStatusCM | PregnancyStatus Concept Map |
http://hl7.org/fhir/us/vrdr/ConceptMap/MethodOfDispositionCM | MethodOfDisposition Concept Map |
http://hl7.org/fhir/us/vrdr/ConceptMap/PlaceOfDeathCM | PlaceOfDeath Concept Map |
http://hl7.org/fhir/us/vrdr/ConceptMap/PlaceOfInjuryCM | PlaceOfInjury Concept Map |
http://hl7.org/fhir/us/vrdr/ConceptMap/SpouseAliveCM | SpouseAlive Concept Map |
http://hl7.org/fhir/us/vrdr/ConceptMap/TransportationIncidentRoleCM | TransportationIncidentRole Concept Map |
http://fhir.ch/ig/ch-core/ConceptMap/maritalstatus-ech11-to-fhir | MaritalStatus eCH-011 to FHIR mapping |
http://hl7.org/fhir/us/vr-common-library/ConceptMap/ConceptMapBirthAttendantTitlesVitalRecords | BirthAttendantTitles Concept Map |
http://hl7.org/fhir/us/vr-common-library/ConceptMap/ConceptMapBirthSexChildVitalRecords | BirthSex Concept Map |
http://hl7.org/fhir/us/vr-common-library/ConceptMap/ConceptMapBirthSexFetusVitalRecords | BirthSex Concept Map |
http://hl7.org/fhir/us/vr-common-library/ConceptMap/ConceptMapEducationLevelVitalRecords | EducationLevel Concept Map |
http://hl7.org/fhir/us/vr-common-library/ConceptMap/ConceptMapHispanicNoUnknownVitalRecords | HispanicNoUnknown Concept Map |
http://hl7.org/fhir/us/vr-common-library/ConceptMap/ConceptMapMaritalStatusVitalRecords | MaritalStatus Concept Map |
http://hl7.org/fhir/us/vr-common-library/ConceptMap/ConceptMapRaceMissingValueReasonVitalRecords | RaceMissingValueReason Concept Map |
http://hl7.org/fhir/us/vr-common-library/ConceptMap/ConceptMapUnitsOfAgeVitalRecords | UnitsOfAge Concept Map |
http://hl7.org/fhir/us/vr-common-library/ConceptMap/ConceptMapYesNoNotApplicableVitalRecords | NotApplicable Concept Map |
http://hl7.org/fhir/us/vr-common-library/ConceptMap/ConceptMapYesNoUnknownNotApplicableVitalRecords | YesNoUnknownNotApplicable Concept Map |
http://hl7.org/fhir/us/vr-common-library/ConceptMap/ConceptMapYesNoUnknownVitalRecords | YesNoUnknown Concept Map |
http://hl7.org/fhir/us/ccda/ConceptMap/CF-NullFlavorDataAbsentReason | C-CDA NullFlavor to FHIR Data Absent Reason |
http://hl7.org/fhir/us/ccda/ConceptMap/FC-DataAbsentReasonNullFlavor | FHIR Data Absent Reason to C-CDA NullFlavor |
http://hl7.org/fhir/us/ccda/ConceptMap/FC-ProcedureStatus | FHIR to C-CDA Procedure Status |
http://hl7.org/fhir/us/bfdr/ConceptMap/BirthAttendantTitlesCM | BirthAttendantTitles Concept Map |
http://hl7.org/fhir/us/bfdr/ConceptMap/BirthDeliveryOccurredCM | BirthDeliveryOccurred Concept Map |
http://hl7.org/fhir/us/bfdr/ConceptMap/FetalDeathCauseOrConditionCM | FetalDeathCauseOrCondition Concept Map |
http://hl7.org/fhir/us/bfdr/ConceptMap/FetalDeathTimePointsCM | FetalDeathTimePoints Concept Map |
http://hl7.org/fhir/us/bfdr/ConceptMap/FetalPresentationCM | FetalPresentation Concept Map |
https://fhir.kbv.de/ConceptMap/KBV_CM_Base_Terminology_Complete_German | KBV_CM_Base_Terminology_Complete_German |
http://nictiz.nl/fhir/ConceptMap/AllergieCategorieCodelijst-to-AllergyIntoleranceCategory | AllergieCategorieCodelijst to AllergyIntoleranceCategory |
http://nictiz.nl/fhir/ConceptMap/ContactTypeCodeLijst-to-ActEncounterCode | ContactTypeCodeLijst to ActEncounterCode |
http://nictiz.nl/fhir/ConceptMap/GeslachtCodelijst-to-AdministrativeGender | GeslachtCodelijst to AdministrativeGender |
http://nictiz.nl/fhir/ConceptMap/NaamgebruikCodelijst-to-HumanNameAssemblyOrder | NaamgebruikCodelijst to HumanNameAssemblyOrder |
http://nictiz.nl/fhir/ConceptMap/VerificatieStatusCodelijst-to-ConditionVerificationStatus | VerificatieStatusCodelijst to ConditionVerificationStatus |
https://fhir.healthdata.be/ConceptMap/BeCivilstate-to-MaritalStatus | BeCivilstate_to_MaritalStatus |
https://fhir.healthdata.be/ConceptMap/NameUsage-to-HumanNameAssemblyOrder | NameUsage_to_HumanNameAssemblyOrder |
http://nictiz.nl/fhir/ConceptMap/CategorieCodelijst-to-AllergyIntoleranceCategory | CategorieCodelijst to AllergyIntoleranceCategory |
http://hl7.it/fhir/lab-report/ConceptMap/ConceptMap-statoCivile | Mapping fra VS HL7 e Tabella ISTAT Stato Civile |
http://hl7.it/fhir/dossier-pharma/ValueSet/vs-NullFlavor | NullFlavor |
http://terminology.ehdsi.eu/ValueSet/eHDSIExceptionalValue | eHDSI Exceptional Value |
http://hl7.org/fhir/ca/baseline/ValueSet/birthsex | Birth Sex |
http://hl7.org/cda/stds/core/ValueSet/CDANullFlavor | CDANullFlavor |
http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-activity-at-time-of-death-vs | Activity at Time of Death ValueSet |
http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-certifier-types-vs | Certifier Types Value Set |
http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-contributory-tobacco-use-vs | Contributory Tobacco Use ValueSet |
http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-death-pregnancy-status-vs | Death Pregnancy Status ValueSet |
http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-method-of-disposition-vs | Method of Disposition ValueSet |
http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-place-of-death-vs | Place of Death ValueSet |
http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-place-of-injury-vs | Place of Injury ValueSet |
http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-spouse-alive-vs | Spouse Alive ValueSet |
http://hl7.org/fhir/us/vrdr/ValueSet/vrdr-transportation-incident-role-vs | Transportation Incident Role ValueSet |
http://hl7.org/fhir/us/vr-common-library/ValueSet/ValueSet-birth-attendant-titles-vr | Value Set - Birth Attendants Titles Vital Records |
http://hl7.org/fhir/us/vr-common-library/ValueSet/ValueSet-education-level-vr | Value Set - Education Level Vital Records |
http://hl7.org/fhir/us/vr-common-library/ValueSet/ValueSet-marital-status-vr | Value Set - Marital Status Vital Records |
http://hl7.org/fhir/us/vr-common-library/ValueSet/ValueSet-race-missing-value-reason-vr | Value Set - Race Missing Value Reason Vital Records |
http://hl7.org/fhir/us/vr-common-library/ValueSet/ValueSet-sex-assigned-at-birth-vr | Value Set - Sex Assigned At Birth Vital Records |
http://hl7.org/fhir/us/vr-common-library/ValueSet/ValueSet-states-territories-provinces-vr | Value Set - States, Territories and Provinces Vital Records |
http://hl7.org/fhir/us/vr-common-library/ValueSet/ValueSet-units-of-age-vr | Value Set - Units of Age Vital Records |
http://hl7.org/fhir/us/vr-common-library/ValueSet/ValueSet-yes-no-not-applicable-vr | Value Set - Yes No Not Applicable Vital Records |
http://hl7.org/fhir/us/vr-common-library/ValueSet/ValueSet-yes-no-unknown-not-applicable-vr | Value Set - Yes No Unknown NotApplicable Vital Records |
http://hl7.org/fhir/us/vr-common-library/ValueSet/ValueSet-yes-no-unknown-vr | Value Set - Yes No Unknown Vital Records |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-radiotherapy-modality-vs | Radiotherapy Modality Value Set |
http://hl7.org/fhir/us/mcode/ValueSet/mcode-radiotherapy-technique-vs | Radiotherapy Technique Value Set |
https://smartforms.csiro.au/ig/ValueSet/PrimaryCarerParentGrandparent | Primary Carer Of Parent Or Grandparent |
http://hl7.eu/fhir/ig/idea4rc/ValueSet/vs-affectedOrgan-eu-i4rc | Affected Organs (surgery) |
http://terminology.hl7.org/ValueSet/gender-identity | Gender Identity |
http://terminology.hl7.org/ValueSet/v3-AskedButUnknown | AskedButUnknown |
http://terminology.hl7.org/ValueSet/v3-ClassNullFlavor | ClassNullFlavor |
http://terminology.hl7.org/ValueSet/v3-NoInformation | NoInformation |
http://terminology.hl7.org/ValueSet/v3-NullFlavor | NullFlavor |
http://terminology.hl7.org/ValueSet/v3-Other | Other |
http://terminology.hl7.org/ValueSet/v3-Unknown | Unknown |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/AxillaSurgeryVS | Axilla surgery ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/BreastSurgeryTypeVS | Types of breast surgery ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ChemoTherapyTypeVS | Type of chemotherapy ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ComplicationImpactVS | Impact of complication ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ComplicationTypeVS | Type of complication ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/EstrogenStatusVS | Estrogen receptor status ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/GermlineMutationVS | Germline Mutation ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/GradingVS | Grading of tumor ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/HistologicalTypeVS | Histological type of the tumor ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/HormonalTherapyTypeVS | Type of hormonal therapy ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/InvolvedMarginsReoperationTypeVS | Re-operation due to involved margins ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/LocationRadiotherapyVS | The location of radiotherapy ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/MenopausalStatusVS | Menopausal status of patient ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/PatientTreatPrefVS | Patient treatment preference ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ProgesteroneStatusVS | Progesterone receptor status ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ReconstructionTypeVS | Type of reconstruction surgery ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/RecurrenceMethodVS | Recurrence method ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/RecurrenceVS | Recurrence of neoplasm ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/RelationshipStatusVS | Relationship status of patient ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ReoperationReasonVS | Reasoncode of the re-operation |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ReoperationTypeVS | Type of re-operation |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/SACQPatientComorbidityHistory | SACQ Patient's comorbidity history ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TNMDistantMetastasesVS | TNM Distant Metastases ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TNMPrimaryTumorVS | TNM Primary Tumor ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TNMRegionalNodesVS | TNM Regional Nodes ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TargetedAxillaSurgeryVS | Targeted axilla surgery ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TargetedTherapyVS | Type of targeted therapy ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TherapyIntentVS | Intent of therapy ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TreatmentPlanNotFollowedVS | Treatment Plan Not Followed ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TreatmentTypeVS | Type of treatments ValueSet |
http://hl7.org/fhir/us/ecr/ValueSet/us-ph-pregnancy-status | US Public Health Pregnancy Status |
http://medcomfhir.dk/ig/terminology/ValueSet/medcom-core-PractitionerRoles | MedComCorePractitionerRoles |
https://profiles.ihe.net/PCC/mPSC/ValueSet/IHE.PCC.mPSC.DataAbsentReason.VS | IHE PCC mPSC Data Absent Reason Value Set |
http://hl7.org/fhir/us/sdoh-clinicalcare/ValueSet/SDOHCC-ValueSetObservationMethod | SDOHCC ValueSet Observation Method |
http://hl7.org/fhir/us/sdoh-clinicalcare/ValueSet/SDOHCC-ValueSetPronounsValue | SDOHCC ValueSet Pronouns Value |
http://hl7.org/fhir/us/davinci-crd/ValueSet/DocReason | CRD Coverage Information Documentation Reason Value Set |
http://hl7.org/fhir/us/davinci-crd/ValueSet/informationNeeded | CRD Information Needed Value Set |
http://fhir.org/guides/hrsa/uds-plus/ValueSet/uds-plus-gender-identity-codes | Uds Plus Gender Identity Codes |
http://fhir.org/guides/hrsa/uds-plus/ValueSet/uds-plus-insurance-codes | Uds Plus Insurance Codes |
http://fhir.org/guides/hrsa/uds-plus/ValueSet/uds-plus-sexual-orientation-codes | Uds Plus Sexual Orientation Codes |
http://hl7.eu/fhir/hdr/ValueSet/poa-indicator-eu-hdr | Condition Present on Admission (POA) Value Set |
https://www.ehealth.fgov.be/standards/fhir/core/ValueSet/be-civilstate | BeCivilState |
https://twcore.mohw.gov.tw/ig/twcore/ValueSet/loinc-pregnancy-intent-code | LOINC + HL7 NullFlavor妊娠計畫值集 |
https://twcore.mohw.gov.tw/ig/twcore/ValueSet/snomed-pregnancy-status-code | SNOMED CT + HL7 NullFlavor妊娠狀態值集 |
https://twcore.mohw.gov.tw/ig/twcore/ValueSet/snomed-sexual-orientation-code | SNOMED CT + HL7 NullFlavor 性傾向值集 |
http://hl7.org/fhir/us/ph-library/ValueSet/us-ph-valueset-pregnancy-status | US Public Health VaueSet - Pregnancy Status |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-birth-attendant-titles | Birth Attendants Titles |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-birth-delivery-occurred | Birth Delivery Occurred |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-fetal-death-cause-or-condition | Fetal Death Cause or Condition |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-fetal-death-time-points | Fetal Death Time Points |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-fetal-presentations | Fetal Presentations |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-fetal-remains-disposition-method | Fetal Remains Disposition Method |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-infections-during-pregnancy-live-birth | Infections During Pregnancy Live Birth |
http://hl7.org/fhir/us/bfdr/ValueSet/ValueSet-newborn-congenital-anomalies | Newborn Congenital Anomalies |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/AxillaSurgeryVS | Axilla surgery ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/BreastSurgeryTypeVS | Types of breast surgery ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ChemoTherapyTypeVS | Type of chemotherapy ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ComplicationImpactVS | Impact of complication ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ComplicationTypeVS | Type of complication ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/EstrogenStatusVS | Estrogen receptor status ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/GermlineMutationVS | Germline Mutation ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/GradingVS | Grading of tumor ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/HistologicalTypeVS | Histological type of the tumor ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/HormonalTherapyTypeVS | Type of hormonal therapy ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/InvolvedMarginsReoperationTypeVS | Re-operation due to involved margins ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/LocationRadiotherapyVS | The location of radiotherapy ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/MenopausalStatusVS | Menopausal status of patient ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/PatientTreatPrefVS | Patient treatment preference ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ProgesteroneStatusVS | Progesterone receptor status ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ReconstructionTypeVS | Type of reconstruction surgery ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/RecurrenceMethodVS | Recurrence method ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/RecurrenceVS | Recurrence of neoplasm ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/RelationshipStatusVS | Relationship status of patient ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ReoperationReasonVS | Reasoncode of the re-operation |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/ReoperationTypeVS | Type of re-operation |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/SACQPatientComorbidityHistory | SACQ Patient's comorbidity history ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TNMDistantMetastasesVS | TNM Distant Metastases ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TNMPrimaryTumorVS | TNM Primary Tumor ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TNMRegionalNodesVS | TNM Regional Nodes ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TargetedAxillaSurgeryVS | Targeted axilla surgery ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TargetedTherapyVS | Type of targeted therapy ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TherapyIntentVS | Intent of therapy ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TreatmentPlanNotFollowedVS | Treatment Plan Not Followed ValueSet |
http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TreatmentTypeVS | Type of treatments ValueSet |
http://hl7.org/fhir/us/core/ValueSet/us-core-documentreference-type | US Core DocumentReference Type |
https://profiles.ihe.net/QRPH/bfdr/ValueSet/ValueSet-yes-no-not-applicable | ValueSet - Yes No NotApplicable |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-orpha-predisposition-eu-pcsp | Hereditary Predispositions (Orphacode) |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-othUnkTxt-eu-pcsp | Other/Unknown/Text |
http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-unknownOther-eu-pcsp | Unknown|Other |
http://hl7.org/fhir/ValueSet/name-assembly-order | HumanNameAssemblyOrder |
https://hl7.fr/ig/fhir/core/ValueSet/fr-core-vs-marital-status | FR Core ValueSet Marital Status ValueSet |
http://fkcfhir.org/fhir/ValueSet/fmc-sexual-orientation-vs | Fresenius Sexual Orientation Value Set |
https://fhir.stichting-nice.nl/ValueSet/NICE-AdministrationRoute | NICE-AdministrationRoute |
https://fhir.stichting-nice.nl/ValueSet/NICE-AdmitSource | NICE-AdmitSource |
https://fhir.stichting-nice.nl/ValueSet/NICE-ContactType | NICE-ContactType |
https://fhir.stichting-nice.nl/ValueSet/NICE-DischargeDisposition | NICE-DischargeDisposition |
https://fhir.stichting-nice.nl/ValueSet/NICE-TreatmentCodelist | NICE-TreatmentCodelist |
https://tx.gerontonet.org/fhir/ValueSet/MedikationsplanPlusPregnancystatus | MedikationsplanPlusVSPregnancystatus |
https://demis.rki.de/fhir/ValueSet/answerSetAcuteHBVD | Anwort akute Infektion aufgrund wessen bei Hepatitis B |
https://demis.rki.de/fhir/ValueSet/answerSetAcuteHCVD | Anwort akute Infektion aufgrund wessen bei Hepatitis C |
https://demis.rki.de/fhir/ValueSet/answerSetBeforeOrAfter1991 | Anwort Vor oder nach 1991 |
https://demis.rki.de/fhir/ValueSet/answerSetCauseDiagnosisMYTD | Anwort Anlass der Diagnose bei Tuberkulose |
https://demis.rki.de/fhir/ValueSet/answerSetCoinfectionHDVD | Anwort Koinfektion mit Hepatitis B bei Hepatitis D |
https://demis.rki.de/fhir/ValueSet/answerSetConservationCLOD | Antwort zur Art der Lebensmittelkonservierung bei Botulismus |
https://demis.rki.de/fhir/ValueSet/answerSetConsumptionCLOD | Antwort zum Ort des Verzehrs bei Botulismus |
https://demis.rki.de/fhir/ValueSet/answerSetCountry | Anwort Country mit staatenlos und Ausland |
https://demis.rki.de/fhir/ValueSet/answerSetDiagnosisCJKD | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Creutzfeldt-Jakob-Krankheit (CJK)" |
https://demis.rki.de/fhir/ValueSet/answerSetFoodCLOD | Antwort zum verzehrten Lebensmittel bei Botulismus |
https://demis.rki.de/fhir/ValueSet/answerSetFormBAND | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Milzbrand" |
https://demis.rki.de/fhir/ValueSet/answerSetFormCDFD | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Clostridioides-difficile-Erkrankung, schwere Verlaufsform" |
https://demis.rki.de/fhir/ValueSet/answerSetFormCJKD | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Creutzfeldt-Jakob-Krankheit (CJK)" |
https://demis.rki.de/fhir/ValueSet/answerSetFormCLOD | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Botulismus" |
https://demis.rki.de/fhir/ValueSet/answerSetFormCORD | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Diphtherie" |
https://demis.rki.de/fhir/ValueSet/answerSetFormMYBD | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Tuberkulose, bei Behandlungsabbruch" |
https://demis.rki.de/fhir/ValueSet/answerSetFormYPSD | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Pest" |
https://demis.rki.de/fhir/ValueSet/answerSetGeographicRegion | Antwort geographische Region |
https://demis.rki.de/fhir/ValueSet/answerSetHospitalizationReason | Antwort Grund der Hospitalisierung |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionAnimalWhereHUSD | Anwort Tierkontakt wo bei Hämolytisch-urämisches Syndrom (HUS) |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionEnvironmentSettingCVDD | Antwortmöglichkeiten zur Angabe des Infektionsumfelds bei dem Meldetatbestand "Coronavirus-Krankheit-2019 (COVID-19)" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionEnvironmentSettingMYTD | Antwortmöglichkeiten zur Angabe des Infektionsumfelds bei dem Meldetatbestand "Tuberkulose" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionPathCJKD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Creutzfeldt-Jakob-Krankheit (CJK)" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionPathHAVD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Hepatitis A" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionPathHBVD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Hepatitis B" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionPathHCVD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Hepatitis C" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionPathHEVD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Hepatitis E" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionPathHUSD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Hämolytisch-urämisches Syndrom (HUS)" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionPathIZVD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Zoonotische Influenza" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionPathMPXD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Mpox" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionPathOPXD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Orthopocken, andere" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionPathWhoHUSD | Antwortmöglichkeiten zur Angabe der Person, bei der sich infiziert wurde, bei dem Meldetatbestand "Hämolytisch-urämisches Syndrom (HUS)" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionRiskAnimalHEVD | Antwort zu Tierkontakt bei Hepatitis E |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionRiskAnimalHUSD | Antwort zu Tierkontakt bei Hämolytisch-urämisches Syndrom (HUS) |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionRiskAnimalRBVD | Antwort zu Tierkontakt bei Tollwut |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionRiskAnimalTTVD | Antwort zu Tierkontakt bei Tollwutexpositionsverdacht |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionRiskCVDD | Antwortmöglichkeiten für die Angabe der Risikofaktoren in Zusammenhang mit dem Meldetatbestand "Coronavirus-Krankheit-2019 (COVID-19)" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionRiskIZVD | Antwortmöglichkeiten für die Angabe der Risikofaktoren in Zusammenhang mit dem Meldetatbestand "Zoonotische Influenza" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionRiskJobHEVD | Antwortmöglichkeiten für die Angabe der beruflichen Risiken in Zusammenhang mit dem Meldetatbestand "Hepatitis E" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionRiskJobHTVD | Antwortmöglichkeiten für die Angabe der beruflichen Risiken in Zusammenhang mit dem Meldetatbestand "Hantavirus-Erkrankung, hämorrhagischer Verlauf" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionRiskNEID | Antwortmöglichkeiten für die Angabe der Risikofaktoren in Zusammenhang mit dem Meldetatbestand "Meningokokken, invasive Erkrankung" |
https://demis.rki.de/fhir/ValueSet/answerSetInfectionRiskOtherHEVD | Antwort zu Sonstiger Kontakt bei Hepatitis E |
https://demis.rki.de/fhir/ValueSet/answerSetLocationLymphNodeSwellingMPXD | Anwort Lokalisation der Lymphknotenschwellung bei Mpox |
https://demis.rki.de/fhir/ValueSet/answerSetLocationMucosalLesionsMPXD | Anwort Lokalisation der Schleimhautläsionen bei Mpox |
https://demis.rki.de/fhir/ValueSet/answerSetLocationSkinLesionsMPXD | Anwort Lokalisation der Hautläsionen bei Mpox |
https://demis.rki.de/fhir/ValueSet/answerSetMajorSiteMYTD | Anwort hauptsächlich betroffenes Organ bei Tuberkulose |
https://demis.rki.de/fhir/ValueSet/answerSetManufacturingCLOD | Antwort zur Art der Lebensmittelherstellung bei Botulismus |
https://demis.rki.de/fhir/ValueSet/answerSetMethodCDFD | Antwortmöglichkeiten für die Angabe der Nachweismethode der Clostridioides-difficile-Erkrankung, schwere Verlaufsform |
https://demis.rki.de/fhir/ValueSet/answerSetMilitaryAffiliation | Antwort Zugehörigkeit zur Bundeswehr |
https://demis.rki.de/fhir/ValueSet/answerSetMinorSiteMYTD | Anwort weiteres betroffenes Organ bei Tuberkulose |
https://demis.rki.de/fhir/ValueSet/answerSetPathogenHFAD | Antwortmöglichkeiten zur Angabe des Erregers bei dem Meldetatbestand "Hämorrhagisches Fieber" |
https://demis.rki.de/fhir/ValueSet/answerSetPregnancyWeek | Anwort Schwangerschaftswoche |
https://demis.rki.de/fhir/ValueSet/answerSetResultOfPrevTreatmentMYTD | Anwort Ergebnis der Vorbehandlung bei Tuberkulose |
https://demis.rki.de/fhir/ValueSet/answerSetResultOfTreatmentMYTD | Anwort Behandlungsergebnis bei Tuberkulose |
https://demis.rki.de/fhir/ValueSet/answerSetStadiumHBVD | Anwort Stadium der Infektion bei Hepatitis B |
https://demis.rki.de/fhir/ValueSet/answerSetStadiumHCVD | Anwort Stadium der Infektion bei Hepatitis C |
https://demis.rki.de/fhir/ValueSet/answerSetTransmissionKindHBVD | Antwortmöglichkeiten für nosokomiale Übertragung bei Hepatitis B |
https://demis.rki.de/fhir/ValueSet/answerSetTransmissionKindHCVD | Antwortmöglichkeiten für nosokomiale Übertragung bei Hepatitis C |
https://demis.rki.de/fhir/ValueSet/answerSetTrimester | Antwort zum Trimester |
https://demis.rki.de/fhir/ValueSet/nullFlavor | NullFlavor |
https://demis.rki.de/fhir/ValueSet/vaccineBAND | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Milzbrand" |
https://demis.rki.de/fhir/ValueSet/vaccineBPSD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Keuchhusten" |
https://demis.rki.de/fhir/ValueSet/vaccineCDFD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Clostridioides-difficile-Erkrankung, schwere Verlaufsform" |
https://demis.rki.de/fhir/ValueSet/vaccineCORD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Diphtherie" |
https://demis.rki.de/fhir/ValueSet/vaccineDEND | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Denguefieber" |
https://demis.rki.de/fhir/ValueSet/vaccineEBVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Ebolafieber" |
https://demis.rki.de/fhir/ValueSet/vaccineGFVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Gelbfieber" |
https://demis.rki.de/fhir/ValueSet/vaccineHAVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Hepatitis A" |
https://demis.rki.de/fhir/ValueSet/vaccineHBVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Hepatitis B" |
https://demis.rki.de/fhir/ValueSet/vaccineHDVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Hepatitis D" |
https://demis.rki.de/fhir/ValueSet/vaccineHEVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Hepatitis E" |
https://demis.rki.de/fhir/ValueSet/vaccineHXXD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Akute Virushepatitis" |
https://demis.rki.de/fhir/ValueSet/vaccineIZVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Zoonotische Influenza" |
https://demis.rki.de/fhir/ValueSet/vaccineMPVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Mumps" |
https://demis.rki.de/fhir/ValueSet/vaccineMPXD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Mpox" |
https://demis.rki.de/fhir/ValueSet/vaccineMSVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Masern" |
https://demis.rki.de/fhir/ValueSet/vaccineMYTD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Tuberkulose" |
https://demis.rki.de/fhir/ValueSet/vaccineNEID | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Meningokokken, invasive Erkrankung" |
https://demis.rki.de/fhir/ValueSet/vaccinePKVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Pocken" |
https://demis.rki.de/fhir/ValueSet/vaccinePOVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Poliomyelitis" |
https://demis.rki.de/fhir/ValueSet/vaccineRBVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Tollwut" |
https://demis.rki.de/fhir/ValueSet/vaccineRUVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Röteln, postnatal" |
https://demis.rki.de/fhir/ValueSet/vaccineSSPD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Subakute Sklerosierende Panenzephalitis (SSPE)" |
https://demis.rki.de/fhir/ValueSet/vaccineSTYD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Typhus" |
https://demis.rki.de/fhir/ValueSet/vaccineSXXD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Paratyphus/Typhus, nicht differenziert" |
https://demis.rki.de/fhir/ValueSet/vaccineTTVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Tollwutexpositionsverdacht" |
https://demis.rki.de/fhir/ValueSet/vaccineVCHD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Cholera" |
https://demis.rki.de/fhir/ValueSet/vaccineVZWD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Windpocken" |
https://demis.rki.de/fhir/ValueSet/vaccineVZZD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Herpes Zoster" |
https://demis.rki.de/fhir/ValueSet/yesOrNoOrNoInformation | Anwort Ja/Nein/nicht erhoben/nicht ermittelbar |
http://ontariohealth.ca/fhir/ValueSet/legal-status | Legal Status |
http://ontariohealth.ca/fhir/ValueSet/personal-income-source | Personal Income Source |
http://ontariohealth.ca/fhir/ValueSet/pre-existing-conditions | Pre-existing Conditions |
http://ontariohealth.ca/fhir/ValueSet/official-language | Preferred Official Language |
http://ontariohealth.ca/fhir/ValueSet/service-termination-reason | Service Termination Reason |
http://ontariohealth.ca/fhir/ValueSet/human-language | Language |
http://ontariohealth.ca/fhir/ValueSet/mha/bornInCanadaResponse | Born in Canada Response |
http://ontariohealth.ca/fhir/ValueSet/employment-status | Employment Status |
http://ontariohealth.ca/fhir/ValueSet/highest-level-of-education-attained | Highest Level of Education Attained |
http://ontariohealth.ca/fhir/ValueSet/sexual-orientation | Sexual Orientation |
http://ontariohealth.ca/fhir/ValueSet/total-household-income | Total Household Income |
http://fhir.de/ValueSet/versicherungsart-de-basis | VersicherungsartDeBasis |
http://ehelse.no/fhir/ValueSet/no-colonoscopy-boston-bowel-preparation-scale | Colonoscopy Report Boston Bowel Preparation Scale |
http://ehelse.no/fhir/ValueSet/no-colonoscopy-complication | Colonoscopy Report Complications |
http://ehelse.no/fhir/ValueSet/no-colonoscopy-complication-consequence | Colonoscopy Report Complication Consequences |
http://ehelse.no/fhir/ValueSet/no-colonoscopy-current-medication | Colonoscopy Report Current Medication |
http://ehelse.no/fhir/ValueSet/no-colonoscopy-followup | Colonoscopy Report Follow Up |
http://ehelse.no/fhir/ValueSet/no-colonoscopy-laxatives | Colonoscopy Report Laxatives |
http://ehelse.no/fhir/ValueSet/no-colonoscopy-laxatives-split-dose | Colonoscopy Report Laxatives Split Dose |
http://ehelse.no/fhir/ValueSet/no-colonoscopy-medication | Colonoscopy Report Medication |
http://ehelse.no/fhir/ValueSet/no-colonoscopy-medication-krg | KRG Medication |
http://ehelse.no/fhir/ValueSet/no-colonoscopy-method-tissue-removal-biopsy | Colonoscopy Report Tissue Removal Method |
http://ehelse.no/fhir/ValueSet/no-colonoscopy-paris-polyp-classification | Colonoscopy Report Colonoscopy Paris Polyp Classification |
http://ehelse.no/fhir/ValueSet/no-colonoscopy-procedure-reason-krg | KRG Indication |
http://ehelse.no/fhir/ValueSet/no-colonoscopy-relevant-conditions | Colonoscopy Report Relevant Conditions |
http://ehelse.no/fhir/valueset/no-colonoscopy-procedure-reason-gastronet | Colonoscopy Report Indication |
https://fake-acme.org/fhir/ValueSet/birthsex | Birth Sex |
https://demis.rki.de/fhir/ValueSet/answerSetAddressUse | Antwortenmöglichkeiten Adressnutzung |
http://hl7.org/fhir/us/mdi/ValueSet/ValueSet-yes-no-unknown-not-applicable | ValueSet - Yes No Unknown NotApplicable |
http://ontariohealth.ca/fhir/ValueSet/gambling-activities-in-last-year | Gambling Activities In Last Year |
http://ontariohealth.ca/fhir/ValueSet/religion-and-spiritual-affiliation | ReligionAndSpiritualAffiliation |
http://fhir.health.gov.il/ValueSet/israel-hmo | Israeli Health Management Organization (קופת חולים) |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.3.2--20200901000000 | AlcoholGebruikStatusCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.8.3.2--20200901000000 | AlertNaamCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.8.2.2--20200901000000 | AllergieCategorieCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.15.1.3--20200901000000 | BestemmingCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.8.6--20200901000000 | ConditiesTijdensMetingCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.15.1.1--20200901000000 | ContactTypeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.4.2--20200901000000 | DrugsGebruikStatusCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.4.1--20200901000000 | DrugsOfGeneesmiddelSoortCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.8.1--20200901000000 | GCS_EyesCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.8.2--20200901000000 | GCS_MotorCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.8.8--20200901000000 | GCS_MotorCodelijstBaby |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.8.7--20200901000000 | GCS_MotorCodelijstKleuter |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.8.3--20200901000000 | GCS_VerbalCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.8.5--20200901000000 | GCS_VerbalCodelijstBaby |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.8.4--20200901000000 | GCS_VerbalCodelijstKleuter |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.0.1.1--20200901000000 | GeslachtCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.17.1.8--20200901000000 | GeslachtCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.15.1.2--20200901000000 | HerkomstCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.5.1--20200901000000 | LevensovertuigingCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.20.4.1--20200901000000 | NaamgebruikCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.121.11.12--20200901000000 | ProductCodeCodelijsten |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.3.1.1--20200901000000 | RelatieCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.19.3.1--20200901000000 | SoortAandoeningCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.2.3--20200901000000 | SoortTabakGebruikCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.5.2.1--20200901000000 | StomaTypeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.8.2.5--20200901000000 | SymptoomCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.2.2--20200901000000 | TabakGebruikStatusCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.4.3--20200901000000 | ToedieningswegCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.5.1.4--20200901000000 | VerificatieStatusCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.15.1--20200901000000 | WilsverklaringTypeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.19.2.5--20200901000000 | WondRandCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.19.2.4--20200901000000 | WondSoortCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.8.1--20200901000000 | WoningTypeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.4.16.2--20200901000000 | ZienHulpmiddelTypeCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.17.1.5--20200901000000 | ZorgverlenerRolCodelijst |
http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-ehdsinullflavor | Cyprus EHR Value Set: eHDSI Null Flavor |
http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-drugormedicationtype | Cyprus EHR Value Set: Drug Or Medication Type |
http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-drugusestatus | Cyprus EHR Value Set: Drug Use Status |
http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-exercise | Cyprus EHR Value Set: Exercise |
http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-findingrelatedtosleep | Cyprus EHR Value Set: Finding Related To Sleep |
http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-respiratoryrhythm | Cyprus EHR Value Set: Respiratory Rhythm |
http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-tobaccotype | Cyprus EHR Value Set: Tobacco Type |
http://ig.ehealth4u.eu/fhir/ValueSet/cyehr-vs-heartrhythm | Cyprus EHR Value Set: Heart Rhythm |
http://terminology.hl7.org/ValueSet/gender-identity | Gender Identity |
http://terminology.hl7.org/ValueSet/v3-AskedButUnknown | AskedButUnknown |
http://terminology.hl7.org/ValueSet/v3-ClassNullFlavor | ClassNullFlavor |
http://terminology.hl7.org/ValueSet/v3-NoInformation | NoInformation |
http://terminology.hl7.org/ValueSet/v3-NullFlavor | NullFlavor |
http://terminology.hl7.org/ValueSet/v3-Other | Other |
http://terminology.hl7.org/ValueSet/v3-Unknown | Unknown |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1006 | Type of Long Term Care Facility |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1010 | Microscopic Exam Culture Site (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1018 | Non Paint Lead Source |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1021 | Number Of Lesions (VZ) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1022 | Occupation Risk Category (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1026 | Pregnancy Trimester |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1032 | Rash Distribution (VZ) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1033 | Rash Location First Noted (VZ) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1035 | Reason Therapy Stopped (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1048 | Strain Type (VZ) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1050 | Batch Deactivation Reason |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1051 | Substance Treatment Refusal Reason |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1052 | Transmission Setting (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1056 | Vaccination Location (CRA) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1058 | Vaccine Purchased With Funds |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1060 | Abnormal Chest X-ray Condition Status |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3015 | Ethnicity Group including Unknown |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3017 | Lab Test Result (PHLIP Flu) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3024 | Blood Contact Frequency (Hepatitis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3025 | Case Confirmation Method |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3026 | Case Detection Method |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3027 | Case Transmission Mode |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3030 | Disease Acquired Jurisdiction |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3033 | Number Of Sex Partners (Hepatitis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3035 | Reason For Test (Hepatitis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3036 | Reporting Source Type |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3037 | Tattoo Obtained From (Hepatitis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3040 | Isolate Not Available EIP Test Reason |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3041 | Isolate Not Received Reason |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3042 | Isolate Not Sent To NARMS Reason |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3046 | Specimen Reshipment Reason |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3048 | Lab Test Interpretation |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3059 | Clinical Syndrome (Arbovirus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3061 | Public Private Lab |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3064 | Yes No Unknown No Answer |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3067 | Virus Variant Type (Animal Rabies) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3068 | Animal Species (Animal Rabies) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3069 | Yes No Unknown Not Done |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3070 | Botulism Food Source Type (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3071 | Pregnancy Outcome (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3072 | Animal Type (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3073 | Botulinum Toxin Type (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3074 | Case Traced to Carrier |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3075 | Cholera Risk Factor (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3076 | Cholera Sequelae (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3077 | Cholera Signs Symptoms (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3078 | Cyclosporiasis Signs Symptoms (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3081 | Fetal Neonatal Infection Type (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3082 | Fetal Neonatal Specimen Type |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3083 | Food Cooking Method (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3084 | Food Processing Method (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3085 | Fresh Berries (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3086 | Fresh Herbs (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3087 | Fresh Produce (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3088 | Information Source |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3090 | Lettuce Type (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3091 | Maternal Infection (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3092 | Meat Purchase Info (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3093 | Non Pork Type (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3094 | Other Related Cases |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3095 | Outbreak Type (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3096 | Pork Type (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3097 | Present Absent Unknown Not Examined |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3098 | Recreational Water (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3099 | Seafood Purchase Info (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3101 | Skin Exposure (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3102 | Skin Exposure Activity (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3103 | Suspected Food Consumed (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3104 | Swimming Pool Type (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3105 | Tap Water Source (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3108 | Travel Purpose |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3109 | Travelers Health Info Source |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3110 | Trichinellosis Signs Symptoms (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3111 | Typhoid Signs Symptoms (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3112 | Underlying Conditions |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3113 | Water Salinity (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3114 | Well Water Treatment (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3115 | Wound History |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3117 | Body Site (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3119 | Acute Convalescent IgG Difference (VPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3120 | Antibiotic Received (Pertussis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3121 | Birth Attendees (VPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3122 | Birth Location (VPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3123 | Birth Outcome (VPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3125 | Case Classification Exposure Source |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3126 | Genotype (Measles) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3127 | Genotype (Rubella) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3128 | Immunization Information Source (CRS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3129 | Injury Occurred Environment (VPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3130 | Injury Type (VPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3134 | No Case Reason (CRS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3137 | Prenatal Care Provider (Rubella) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3138 | Relationship (VPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3140 | Specimen Source (CRS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3141 | Specimen Source (VPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3142 | Test Method EIA IgM |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3143 | Tetanus Type (VPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3144 | Treatment Outcome Tetanus (VPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3145 | Vaccine Doses Received (Pertussis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3146 | Vaccine Doses Received (Tetanus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3147 | Medication Received (VZ) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3148 | PCR Specimen Source (VZ) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3150 | IgM Test Type (VZ) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3151 | IgG Test Type (VZ) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3154 | Vaccines Administered (VZ) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3159 | Reporting Lab Type |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3161 | Primary Reason For Evaluation (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3162 | Risk Factors (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3163 | Immigration Status |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3164 | Sputum Culture Conversion Not Documented Reason |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3166 | Cause of Death Related to TB |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3167 | Therapy Extended Reason (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3169 | Birth Country (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3200 | Birth Country |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3201 | Geographical location history |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3244 | Medication Treatment (Flu) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3246 | Specimen (Flu) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3254 | Employment Status (Flu) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3259 | Age Group (Flu) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3261 | Death Location (Flu) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3264 | Sterile Specimen (Pediatric Flu) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3265 | Positive Negative Unknown |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3266 | Microorganism (Pediatric Flu) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3267 | Non-Sterile Specimen (Pediatric Flu) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3268 | Acute Illness Complications (Pediatric Flu) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3269 | Underlying Conditions (Pediatric Flu) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3301 | Lab Test Interpretation (VPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3302 | Lab Test Procedure (Measles) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3303 | Specimen Source (Measles) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3304 | Parotitis Laterality (Mumps) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3305 | Type of Deafness (Mumps) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3306 | Lab Test Procedure (Mumps) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3307 | Specimen Source (Mumps) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3308 | Complications (Malaria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3310 | Medication Missed (Malaria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3311 | Medication Prophylaxis (Malaria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3312 | Medication Treatment (Malaria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3313 | Species (Malaria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3314 | Specimen Type (Malaria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3315 | Travel Reason (Malaria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3316 | Antimicrobial Agent (IPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3318 | Bacterial Infection Syndrome (IPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3319 | Oxacillin Interpretation (IPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3320 | Serotype Method (IPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3321 | Sterile Specimen (IPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3322 | Underlying Conditions (IPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3323 | Birth Outcome (Rubella) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3336 | Susceptibility Result (IPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3402 | Age Unit (Syndromic Surveillance) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3405 | Race Category including Unknown |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3406 | Disease Acquired Jurisdiction (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3407 | Case Class Status (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3408 | Age Unit (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3409 | Transmission Setting (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3410 | Vaccine Not Given Reasons (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3412 | Injury Occurred Environment (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3413 | Injury Type (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3414 | Birth Attendees (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3415 | Vaccines Administered (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3416 | Manufacturers Of Vaccines (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3417 | Contact Type Hepatitis A (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3418 | Sexual Preference (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3419 | Lab Test Result Lyme (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3420 | Microorganism (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3421 | Bacterial Infection Syndrome (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3422 | Associated Conditions (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3423 | Antibiotic Treatment (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3425 | Geographic Region (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3432 | Serogroup (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3435 | Serotype (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3598 | Wound Depth Tetanus (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3599 | Time Period Tetanus (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3600 | Stay Period Hepatitis (NETSS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4005 | Lab Result (Babesiosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6001 | Certifier Types (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6003 | Pregnancy Status (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6004 | Contributory Tobacco Use (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6005 | Transportation Relationships (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6070 | Infections During Pregnancy - Live Birth (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7103 | VPD Laboratory Coded Observation |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7104 | VPD Specimen Type |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7111 | Birth Attendant Titles (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7112 | Fetal Death Time Points (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7113 | Fetal Presentations (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7124 | Birth or Delivery Occurred (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7135 | Infections During Pregnancy Fetal Death (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7166 | Binational Reporting Criteria (BIDS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7167 | Case Transmission Mode (BIDS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7170 | Specimen Site (BIDS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7171 | Salmonella Serogroup (BIDS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7174 | Campylobacter Nonculture Test Type (BIDS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7176 | STEC Nonculture Test Type (BIDS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7177 | E. coli Shiga Toxin Test Type (BIDS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7178 | E. coli Shiga Toxin (BIDS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7179 | Vibrio Culture Species (BIDS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7180 | Vibrio Serotype (BIDS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7181 | Vibrio Biotype (BIDS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7182 | Vibrio Cholera Toxin Test Type (BIDS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7188 | Travel Reason (Hepatitis A) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7189 | Specimen Source (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7191 | Syphilis Neurologic Involvement (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7192 | HIV Status (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7193 | YNRD (CDC) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7195 | Clinician Observed Lesions (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7199 | Detection Method (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7203 | Quantitative Syphilis Test Result (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7204 | Race Category including Refused |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7205 | Race Category including Null Flavor |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7206 | Lab Test Result Qualitative (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7212 | Certifier Titles (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7216 | Place of Death (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7217 | Lab Test Reactivity (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7218 | Syphilis Clinical Stage (CS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7219 | Syphilis Surveillance Stage (CS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7220 | Pregnancy Treatment Stage (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7221 | Syphilis Treatment Mother (CS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7223 | Birth Status (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7224 | Darkfield DFA Result (CS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7225 | Signs Symptoms (CS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7226 | X-Ray Result (CS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7227 | VDRL Test Result (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7228 | CSF WBC Protein Result (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7229 | Syphilis Treatment Infant (CS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7247 | Symptoms (EVD Triage) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7249 | Exposure Risk (EVD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7265 | Duration Unit |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7269 | Reason for Missing Test (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7270 | Lab Test Result Interpretation (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7279 | Non-Treponemal Test Result (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7282 | Complications (Mumps) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7283 | Signs and Symptoms (Mumps) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7284 | Signs and Symptoms (Pertussis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7285 | Complications (Pertussis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7329 | Type of Testing at CDC (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7330 | Performing Laboratory Type (VPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7331 | Vaccine Administered (MMR) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7332 | Setting of Further Spread |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7333 | Timing of Maternal Treatment (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7334 | Lab Test Interpretation (Pertussis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7335 | Vaccine Administered (Pertussis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7359 | Point of Origin (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7361 | Disposition OPD (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7362 | Follow-up Attempt Outcome (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7365 | Priority (Type) of Admission or Visit (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7369 | Present on Admission (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7372 | Time Units (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7373 | Race (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7374 | Place of Injury (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7375 | Ethnicity Group (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7376 | Ethnicity Detail (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7379 | Methods of Disposition (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7385 | Decedent Education Level (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7422 | Fetal Death Cause or Condition (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7437 | Disposition ED (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7441 | Neurological Manifestation (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7446 | States Territories Provinces (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7448 | Vaccine Type (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7450 | Vaccine Event Information Source (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7451 | Type of Testing at CDC (VZ) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7452 | Age Unit (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7453 | Body Region(s) of Rash |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7454 | Character of Lesions |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7473 | Diagnostic Lab Test Findings (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7474 | Type of Complication (VZ) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7478 | Serotype (Dengue) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7486 | Yes No Not Applicable (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7487 | Reason for Hospitalization (VZ) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7490 | Clinical Syndrome - Secondary (Arbovirus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7495 | Serotype (Arbovirus) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7537 | Duration Unit (1) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7538 | Type of Complication (Babesiosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7539 | Medication Treatment (Babesiosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7540 | Blood Product |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7541 | Clinical Manifestations (Babesiosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7544 | Outdoor Activities |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7551 | Test Result Coded Qualitative |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7553 | Specimen Type AST (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7554 | Specimen Collection Site AST (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.756 | Gender Identity |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7563 | Sexual Orientation |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7582 | Vital Records Education Level (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7585 | Fetal Remains Disposition Method (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7607 | Type of Testing at CDC |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7608 | Type Of Complication (CRS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7609 | Sexual Orientation (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7610 | Gender Identity (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7611 | Clinical Manifestations (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7612 | Late Clinical Manifestation (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7615 | Pre-Pregnancy SerologicalTestInterp (CRS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7616 | Specimen From Mother Or Infant (CRS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7617 | Organism (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7618 | Yes No Unknown Refused (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7619 | Antibiotics (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7620 | Antacids (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7621 | Signs and Symptoms (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7623 | Test Method (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7625 | Test Type (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7626 | Test Result (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7627 | Specimen Collection Source (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7628 | Yes No Unknown Maybe (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7629 | Yes No Don't Know Maybe (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7630 | Drinking Water (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7631 | Recreational H2O Treatment (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7632 | Raw Unpasteurized Products (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7633 | Day Care Setting (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7634 | Sexual Contact (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7635 | Medication Administered (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7636 | Medical History (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7637 | Seafood Preparation (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7638 | Seafood Source (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7639 | Shellfish Distributed (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7640 | Improper Handling Storage (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7644 | Vibrio Cholera Serotype (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7645 | Vibrio Cholera Biotype (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7649 | Signs and Symptoms (Rubella) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7650 | Type Of Complication (Rubella) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7651 | Previous Case Diagnosed By (Rubella) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7653 | Specimen Type (CRS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7655 | PCR Specimen Source (CRS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7656 | Specimen Source (Rubella) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7657 | Specimen Type (Rubella) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7659 | Type of Testing at CDC(Rubella) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7660 | Type of Complication (Measles) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7662 | Signs and Symptoms (Measles) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7666 | Signs and Symptoms (Trich) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7668 | Meat Consumed Type (Trich) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7669 | Food Processing Method (Trich) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7670 | Meat Purchase Info (Trich) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7671 | Food Cooking Method (Trich) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7672 | Performing Lab Type (Trich) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7674 | Lab Test Interpretation (Trich) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7675 | Specimen type (Trich) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7676 | Strain Type (Trich) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7678 | Discharge Location (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7679 | Pregnancy Status (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7680 | Fetal Outcome (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7681 | Underlying Condition (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7682 | Smoking Status (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7683 | Substance Abuse (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7684 | Mode of Delivery (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7686 | Microorganism (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7687 | Performing Lab Type (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7688 | Vaccine Type (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7689 | Vaccination Information Source (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7691 | GAS Risk Factor Interval (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7693 | Antibiotic Received (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7695 | Antibiotic Reason (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7696 | Detection Method (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7697 | Birth Location (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7698 | Gestational Age Determination (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7699 | Susceptibility Data NA (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7700 | AR Agent (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7702 | ATI Method (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7704 | Susceptibility Interpretation (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7706 | Sequelae (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7709 | Delivery Type (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7710 | Medication Pre-Treatment (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7711 | Contact Type (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7712 | School Year (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7713 | College Living Situation (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7715 | Legionella Exposure (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7716 | Definitely Possibly No (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7717 | Legionella Exposure Setting (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7718 | Healthcare Exposure Type (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7719 | Facility Type (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7720 | Water Source (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7721 | Cruise Line (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7722 | Titer Test Type (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7723 | Signs and Symptoms (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7724 | Personal Protective Equipment (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7725 | Respiratory Protective Equipment (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7726 | Glove Material (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7727 | Titer Test Method (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7728 | Bird Type (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7729 | Establishment Type (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7730 | Residence Location (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7731 | Insurance Type (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7732 | Infection Type (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7733 | Lab Test Method (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7734 | Lab Test Interpretation (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7735 | SPN/IPD Serotype (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7736 | Serotype Method (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7737 | Legionellosis Serogroup (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7740 | Colony Count Magnitude |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7744 | Lab Test Interpretation (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7745 | Type of Radiology Study |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7746 | Result of Radiology Study (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7747 | Diabetes Status |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7748 | Epidemiological Risk Factors (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7751 | Type of Link (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7755 | LTBI Drug Regimen (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7756 | Reason LTBI Not Started (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7757 | Reason LTBI Treatment Stopped (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7759 | Medication (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7761 | Susceptibility Test Interpretation (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7762 | Susceptibility Test Method (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7763 | Gene Name (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7764 | Molecular Test Results (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7765 | Molecular Indel (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7766 | Molecular Test Methods (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7767 | Reason Not Treated with RIPE (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7769 | Final Treatment Outcome (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7772 | Side Effect of Treatment (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7773 | Serogroup Method (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7774 | Specimen Type (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7778 | Specimen Site (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7779 | Condition Status (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7785 | Extended Race Group (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7787 | Food Allergy (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7789 | Fruit (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7790 | Heated Food (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7791 | Hispanic Ethnic Group (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7792 | Illness (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7793 | Likely Contact (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7794 | LikelyAte (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7795 | Medical History (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7796 | Patient Type (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7797 | Birth Location (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7798 | Pregnancy Outcome (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7799 | Reason Not Interviewed (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7800 | Respondent (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7801 | Signs and Symptoms (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7802 | Specimen Type (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7803 | Yes No Unknown Refused (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7804 | Patient Outcome (Listeria) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7806 | Assisted Living Exposure Type (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7808 | N. meningitidis Serogroup (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7809 | H. influenzae Serotype (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7812 | Case Type (CP-CRE) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7813 | Specimen Source (CP-CRE) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7823 | Lab Test Interpretation (Legionellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7825 | Gene Name (CP-CRE) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7826 | Specimen Source Site (VPD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7832 | Clinical Manifestation (TBRD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7833 | Complications (TBRD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7834 | Medication Received (TBRD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7836 | Organism (TBRD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7837 | Coinfection Type (TBRD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7838 | Specimen Type (TBRD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7839 | Medication Received (Lyme) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7840 | Clinical Manifestations (Lyme) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7841 | Specimen Type (Lyme) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7843 | Organism (Lyme) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7845 | Serotype Master (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7846 | Lab Test Interpretation Master (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7848 | Exposure Setting Master (RIBD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7849 | Usual Occupation and Industry (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7850 | Organism (CP-CRE) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7851 | Contact Type (FDD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7852 | Geographic Location |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7861 | Death Reporting Decedent and Certificate Identifier Type (HL70203) (NCHS) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7862 | Test Result (CP-CRE) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7864 | Specimen Source (C. auris) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7866 | Lab Test Method (MDRO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7868 | Type of Long Term Care Facility (C. auris) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7869 | Specimen Collection Setting Type (C. auris) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7870 | Type of Co-infection (C. auris) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7874 | Poison Control Center Record (CO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7875 | Workers Compensation Record (CO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7876 | Intent of Exposure (CO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7877 | Extreme Weather Type (CO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7878 | Exposure Source (CO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7879 | Treatment Type (CO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7880 | Education (CO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7881 | Generator Location (CO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7882 | Generator Distance (CO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7883 | Person/Organization Taking CO Reading (CO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7884 | Exposure Site Category (CO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7885 | Public Site of Exposure (CO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7886 | Treatment Location (CO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7887 | Underlying Conditions (CO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7888 | Signs and Symptoms (CO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7889 | ICD Codes List (CO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7890 | Treatment Site (CO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7891 | Data Reporting Source (CO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7896 | Residential Site of Exposure (CO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7907 | Ethnicity (ARLN) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7908 | Gender (ARLN) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7914 | Acinetobacter culture result (ARLN) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7921 | Specimen type (ARLN) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7922 | Microorganism (ARLN) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7923 | Medication Treatment (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7925 | Type of Complication (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7926 | Number of Cigarettes Smoked per Day (CO) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7927 | Dose Unit (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7928 | Lab Test Result Qualitative (Syphilis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7929 | Medication Route (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7930 | Route of Administration (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7931 | Medication Frequency Unit (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7932 | Duration Units (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7934 | Microorganism (STD) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7936 | Contact Type (COVID-19) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7938 | Detection Method (COVID-19) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7939 | Residence Type (COVID-19) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7940 | Healthcare Occupation (COVID-19) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7941 | Job Setting (COVID-19) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7942 | Exposure Setting (COVID-19) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7943 | Data Reporting Source (COVID-19) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7944 | Signs and Symptoms (COVID-19) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7945 | Clinical Finding (COVID-19) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7946 | Animal Type (COVID-19) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7947 | Risk Factor (COVID-19) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7949 | Treatment Type (COVID-19) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7950 | Yes No Unknown NA (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7951 | Reason for Test (COVID-19) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7952 | Tribe Name (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7953 | Critical Infrastructure Sector (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7954 | Medication Administered (Hansen) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7956 | Type of Leprosy (Hansen) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7957 | Relationship (Hansen) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7958 | Hospital Procedure (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7959 | Underlying Condition(s) (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7960 | Disease Outcome Type (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7961 | Medication (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7962 | Contact Type (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7963 | Medication Administered (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7965 | Sick Animal Type (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7966 | Rodent Type (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7967 | Animal Type (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7968 | Clinical Manifestations (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7969 | Specimen Type (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7970 | Disease Stage (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7971 | Animal Type (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7972 | Medication (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7973 | Diagnostic Test Finding (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7974 | Specimen Type (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7975 | Specimen Source Site (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7976 | Test Titer Type (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7977 | Brucella Exposure (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7978 | Exposure Risk (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7979 | Previous Treatment Duration (Hansen) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7980 | Patient Case Status (Hansen) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7981 | Animal Ownership (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7982 | Vaccine Exposure (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7984 | Hospital Procedure (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7985 | Actual Route of Administration (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7986 | Performing Lab Type (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7987 | Country of Product Acquisition (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7988 | Location Type (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7989 | Clinical Outcome (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7990 | Specimen Type (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7991 | Procedure Type (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7992 | Public TransportationType (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7994 | Exposure Type (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7995 | Diet Type (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7996 | Post-exposure or Treatment (NND) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7997 | Treatment Type (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7999 | Animal Type (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8000 | Test Results Anthrax |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8002 | Reason Medication Not Completed (BSP) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8003 | Smoking Status (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8004 | Test Results (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8005 | Antimicrobials (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8006 | Contact Type (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8007 | Clinical Manifestations (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8008 | Clinical Manifestations (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8009 | Exposure Location (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8010 | Organism Name (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8011 | Activity Type (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8012 | Activity Type (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8013 | Exposure Source (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8014 | Activity Type Anthrax |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8015 | Food Product Consumed (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8016 | Fresh Water or Mud Type (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8017 | Exposure Source (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8021 | Total Doses of Vaccine (Anthrax) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8024 | Medication Completed (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8029 | Division Vital Statistics (County) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8030 | Lab Test (Hansen) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8033 | Frequency Duration Unit (Hansen) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8036 | Antibiotic Dose Units (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8037 | Test Type (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8038 | Specimen Source Site (Brucellosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8039 | Test Results (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8040 | Pregnancy Outcome (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8041 | Lab Test Type (Leptospirosis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8042 | Test Result (Hepatitis A) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8043 | HBeAg Test Result (Hepatitis B Perinatal) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8044 | Infant Nucleic Acid Test Result (Hepatitis C) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8045 | Infant HCV Antigen Test Result (Hepatitis C) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8046 | Mother Nucleic Acid Test Result (Perinatal Hep) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8048 | Common-Source Outbreak (Hepatitis B) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8049 | Common-Source Outbreak (Hepatitis C) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8051 | Patient Epidemiological Risk Factors (Hepatitis A) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8052 | Patient Epidemiological Risk Factors (Hepatitis B) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8053 | Patient Epidemiological Risk Factors (Hepatitis C) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8054 | Alanine aminotransferase (ALT) Result (Hepatitis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8055 | Source of Laboratory Test (Hepatitis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8056 | HBsAg Test Result (Hepatitis B Perinatal) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8057 | Infant Anti-HCVTest Result (Hepatitis C Perinatal) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8060 | Test Result (Hepatitis) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8061 | HBV DNA Test Result (Hepatitis B Perinatal) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8062 | Gender Identity (USCDI) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8063 | Sexual Orientation (USCDI) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.8064 | Travel Purpose (CDC) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.828 | Country |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.829 | County |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.831 | Language |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.875 | Null Flavor (HL7 V3) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.878 | Age unit |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.888 | Yes No Unknown (YNU) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.921 | Emergency Department Acuity |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.929 | Positive Negative Unknown Not Done |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.930 | Chest XRay Result |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.931 | Vaccine Not Given Reason |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.941 | Susceptibility Result |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.950 | Passed Failed Unknown |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.957 | Abnormal Chest X-Ray Finding (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.959 | Additional Site of Disease (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.968 | Case Classification Status |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.970 | Case Investigation Status |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.979 | Type of Correctional Facility |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.980 | Diagnosed by (VZ) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.981 | Diagnosed Pneumonia By (VZ) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.982 | Directly Observed Therapy (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.983 | Sites of Directly Observed Therapy (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.985 | Employment Status |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.992 | Epilinked Case Type (VZ) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.994 | General Condition Status |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.995 | Health Care Practice Type (TB) |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.997 | HIV Diagnosis Based On |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.998 | HIV Status |
http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.3.20 | Specimen Source Site (Anthrax) |
http://hl7.org/fhir/us/core/ValueSet/omb-race-category | OMB Race Categories |
https://signalbhn.org/fhir/ValueSet/fips-county-co | CO FIPS Counties |
http://hl7.org/fhir/us/core/ValueSet/birthsex | Birth Sex |
http://hl7.org/fhir/us/core/ValueSet/detailed-ethnicity | Detailed ethnicity |
http://hl7.org/fhir/us/core/ValueSet/detailed-race | Detailed Race |
http://hl7.org/fhir/ValueSet/encounter-special-courtesy | Special courtesy |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.32 | Gender Identity |
http://hl7.org/fhir/us/core/ValueSet/omb-ethnicity-category | OMB Ethnicity Categories |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.9--20160407000000 | Aanvullende gebruiksinstructie |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.57--20241101000000 | Financiële Indicatiecode |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.47--20240131165054 | MedicatieToedieningRedenVanAfwijkenCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.53--20220323181942 | PrikPlakLocatieCodeLijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.42--20221114132525 | RedenWijzigen-StakenCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.54--20221114181621 | RedenWijzigen-StakenWDSCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.43--20221115122002 | RedenWijzigen-StoppenGebruikCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.49--20221115120643 | Toedieningsafspraak-RedenWijzigen-StakenCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.44--20220302105041 | Voorstel antwoord medicatieafspraak |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.20.77.11.36--20180412153353 | Voorstel antwoord verstrekkingsverzoek |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.9.12.4--20200901000000 | ZonodigCriteriumCodelijst |
https://www.ehealth.fgov.be/standards/fhir/vaccination/ValueSet/be-vs-vaccination-administration-route | BeVSVaccineAdministrationRoute |
https://www.ehealth.fgov.be/standards/fhir/ValueSet/be-civilstate | BeCivilstate |
https://www.ehealth.fgov.be/standards/fhir/ValueSet/be-vs-vaccination-administration-route | Vaccine Administration Route |
https://demis.rki.de/fhir/ars/ValueSet/stationstyp | Stationstyp |
https://fhir.healthdata.be/ValueSet/AdministrationDevice | AdministrationDevice |
https://fhir.healthdata.be/ValueSet/ConditionsDuringMeasurement | ConditionsDuringMeasurement |
https://fhir.healthdata.be/ValueSet/DeviatingBreathingPattern | DeviatingBreathingPattern |
https://fhir.healthdata.be/ValueSet/EstimatingMethod | EstimatingMethod |
https://fhir.healthdata.be/ValueSet/FamilyComposition | FamilyComposition |
https://fhir.healthdata.be/ValueSet/FamilyCompositionChild | FamilyCompositionChild |
https://fhir.healthdata.be/ValueSet/FeedingTubeType | FeedingTubeType |
https://fhir.healthdata.be/ValueSet/InfusionCatheterType | InfusionCatheterType |
https://fhir.healthdata.be/ValueSet/LifeStance | LifeStance |
https://fhir.healthdata.be/ValueSet/LineStatus | LineStatus |
https://fhir.healthdata.be/ValueSet/StomaType | StomaType |
https://fhir.healthdata.be/ValueSet/TypeOfDisorder | TypeOfDisorder |
https://fhir.healthdata.be/ValueSet/UrineCatheterType | UrineCatheterType |
https://fhir.healthdata.be/ValueSet/VisualAcuityMeasurementChart | VisualAcuityMeasurementChart |
https://fhir.healthdata.be/ValueSet/VisualAcuityMeasurementDevice | VisualAcuityMeasurementDevice |
https://fhir.healthdata.be/ValueSet/VisualAcuityType | VisualAcuityType |
https://fhir.healthdata.be/ValueSet/WoundEdge | WoundEdge |
https://fhir.healthdata.be/ValueSet/WoundType | WoundType |
https://fhir.nhs.uk/ValueSet/NHSDigital-VaccineCode | NHS Digital Vaccine Code |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.26.11.7--20211028090253 | CategorieCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.26.11.41--20240910090504 | StartRedenCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.26.11.40--20240909075522 | StopRedenCodelijst |
http://decor.nictiz.nl/fhir/ValueSet/2.16.840.1.113883.2.4.3.11.60.26.11.14--20231120120019 | WijzeVanVaststellenCodelijst |
https://furore.com/data/fhir/ValueSet/PatientComorbidityHistory | Patient's comorbidity history ValueSet |
http://hl7.it/fhir/lab-report/ValueSet/istat-comune | ISTAT - Comuni |
http://hl7.it/fhir/lab-report/ValueSet/istat-provincia | ISTAT - Province |
http://hl7.it/fhir/lab-report/ValueSet/statoCivile | Stato Civile |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.102 | Unknown or refused to answer |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.103 | Other or unknown or refused to answer |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.24 | Birth Sex |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.10 | Other Unknown Nulls |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.11 | Sexual Orientation Including nulls and Data Absent Reason |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.12 | Pregnancy Status Observation |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1240.2 | No Healthcare Agent Included Reason |
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.1.11.10612 | Unknown Null |
https://ths-greifswald.de/fhir/ValueSet/gics/PolicyStatus | PolicyStatus |
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.